Results 121 to 130 of about 1,757,150 (280)
Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone
A serosurvey of anti-Ebola Zaire virus nucleoprotein IgG prevalence was carried out among Ebola virus disease survivors and their Community Contacts in Bombali District, Sierra Leone. Our data suggest that the specie of Ebola virus (Zaire) responsible of
Nadege Goumkwa Mafopa +13 more
doaj +1 more source
Monoclonal Antibody Therapy for Ebola Virus Disease.
Early reports in 1976 and 1995 documented cases in the Democratic Republic of Congo (DRC) of what we now know to be Ebola virus disease (EVD) caused by Zaire ebolavirus.
M. Levine
semanticscholar +1 more source
ABSTRACT The coupling of replication and encapsidation in the bipartite plant virus, cowpea mosaic virus (CPMV), has been used to specifically incorporate designer RNA molecules into viral particles via transient expression in Nicotiana benthamiana. This is achieved by placing the desired RNA sequence between the 5′ and 3′ UTRs of CPMV RNA‐2 so that ...
H. Peyret +5 more
wiley +1 more source
Since the largest 2014–2016 Ebola virus disease outbreak in West Africa, understanding of Ebola virus infection has improved, notably the involvement of innate immune mediators.
Anne-Laure Favier +8 more
doaj +1 more source
The Western Africa Ebola virus disease epidemic exhibits both global exponential and local polynomial growth rates [PDF]
Gerardo Chowell +3 more
openalex +1 more source
An overview of Ebola virus disease
(Uploaded by Plazi for the Bat Literature Project) Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat.
Kadanali, Ayten, Karagoz, Gul
openaire +2 more sources
Long-lasting severe immune dysfunction in Ebola virus disease survivors
Long-term follow up studies from Ebola virus disease (EVD) survivors (EBOV_S) are lacking. Here, we evaluate immune and gene expression profiles in 35 Guinean EBOV_S from the last West African outbreak, a median of 23 months (IQR [18–25]) after discharge
A. Wiedemann +23 more
semanticscholar +1 more source
ABSTRACT Plants are promising next‐generation hosts for recombinant protein production; however, major challenges remain with regard to enhancing the efficiency of downstream processing, particularly in the removal of cellular residues and purification of the expressed proteins.
Hiroyuki Kajiura +3 more
wiley +1 more source

